What does CUSIP 69329YAG9 represent in this 13F holders report?

CUSIP 69329YAG9 is the security identifier for 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 used to aggregate holder disclosures.

How many institutions held 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in Q4 2020?

No institutional holders were reported for 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in Q4 2020; review adjacent reporting periods for trend context.

PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Debt / NOTE 2.750%12/0
Total 13F principal: $0
Principal change: -$1,967,000
Total reported market value: $0
Number of holders: 0
Value change: -$2,131,773
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 69329YAG9:

Q4 2021 Q3 2021 Q2 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019

PDL BIOPHARMA INC - NOTE 2.750%12/0

Q4 2020 13F Holders as of 31 Dec 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q4 2020.